BioAtla, Inc. (BCAB) Tops Q4 EPS by 6c

BioAtla, Inc. (NASDAQ: BCAB) reported Q4 EPS of ($0.16), $0.06 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $2 million.

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• Phoenix Education Partners, Inc. (PXED) Misses Q3 EPS by 14c; Offers Outlook
• BrightSpring to join S&P MidCap 400, Karman to join SmallCap 600
• Gladstone Land Announces Monthly Cash Distributions for July, August and September 2026 and Earnings Release and Conference Call Dates for the Second Quarter Ended June 30, 2026